Sort
78,016 grants matching “breast cancer”
Modeling to Minimize Detection Bias in Cancer Risk Prediction Studies
$454,280Ruth D Etzioni · Fred Hutchinson Cancer Research Center · R01 · FY2019 · CA
Web-Based Support for Informal Caregivers in Cancer
$454,253David H Gustafson · University Of Wisconsin-Madison · R01 · FY2006 · NR
Racial/Ethnic Disparities In Work and Qol Outcomes In Survivors of Breast Cancer
$454,206Steven J. Katz · University Of Michigan At Ann Arbor · R01 · FY2009 · CA
Epigenetics of the Retinoic Acid Paradox
$454,197Nicoletta Sacchi · Roswell Park Cancer Institute Corp · R01 · FY2011 · CA
Molecular Mechanisms underlying tRNA-fragment regulation of cancer
$454,192Sohail F. Tavazoie · Rockefeller University · R01 · FY2020 · CA
A kinase-independent role for EGFR in p38MAPK suppression and S-phase progression in head and neck cancer
$454,116Alan C Rapraeger · University Of Wisconsin-Madison · R01 · FY2022 · DE
The role of microhomology-mediated end joining in Fanconi anemia pathogenesis
$454,090Neil Johnson · Research Inst Of Fox Chase Can Ctr · R01 · FY2022 · HL
Symptom Management After Breast Cancer Surgery
$454,078Christine A. Miaskowski · University Of California, San Francisco · R01 · FY2006 · CA
Vanderbilt Clinical Oncology Research Career Development Award
$454,075Wendy K Rathmell · Vanderbilt University Medical Center · K12 · FY2016 · CA
Harnessing E3 Ligases for Cancer Therapy
$454,038Daniel Nomura · University Of California Berkeley · R01 · FY2022 · CA
Behavioral and Psychological Impact of Returning Breast Density Results to Latinas
$454,024Celine M Vachon · Mayo Clinic Rochester · R01 · FY2019 · MD
Human and Computer Mentors for Prostate Cancer Patients
$454,018Robert P Hawkins · University Of Wisconsin-Madison · R01 · FY2008 · CA
Pentraxin-3 in the Pathogenesis and Management of Triple-Negative Breast Cancer
$454,009Antoine Elias Karnoub · Beth Israel Deaconess Medical Center · R01 · FY2023 · CA
Patient Oriented Outcomes of Prophylactic Mastectomy
$454,001Kaiser Foundation Research Institute · R01 · FY2003 · CA
Exosome secretion in breast cancer progression
$453,988Alissa M Weaver · Vanderbilt University · R01 · FY2025 · CA
Clinical, Basic, Translational and Kinetic Studies of Drug Action and Resistance
$453,967Antonio Fojo · Division Of Clinical Sciences - Nci · ZIA · FY2013 · CA
Project 3: Understanding genomic and external drivers of response-predictive inflammatory states underlying differences in clinical outcomes in patients with breast cancer
$453,954Elad Ziv · University Of California, San Francisco · U54 · FY2025 · CA
Discovery and Development of Cancer Glycomarkers
$453,938James Michael Pierce · University Of Georgia · U01 · FY2015 · CA
Repurposing Glucosylceramide Synthase to Promote Mitochondrial Lethality and Potentiate an Anti-Tumor Immune Response in Triple-Negative Breast Cancer
$453,927Johannes F Fahrmann · University Of Tx Md Anderson Can Ctr · R37 · FY2024 · CA
The Development of TGR5 Antagonists for the Treatment of Cholangiopathies
$453,913Steven H Olson · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2022 · DK
Urinary matrix metalloproteinases and breast cancer risk in a prospective cohort
$453,911Lesley M Butler · University Of Pittsburgh At Pittsburgh · R01 · FY2012 · CA
Bioluminecence-activated photodynamic therapy of breast cancer
$453,878Seok H Yun · Massachusetts General Hospital · R01 · FY2015 · CA
Bioluminecence-activated photodynamic therapy of breast cancer
$453,878Seok H Yun · Massachusetts General Hospital · R01 · FY2016 · CA
Bioluminecence-activated photodynamic therapy of breast cancer
$453,878Seok H Yun · Massachusetts General Hospital · R01 · FY2018 · CA
Bioluminecence-activated photodynamic therapy of breast cancer
$453,878Seok H Yun · Massachusetts General Hospital · R01 · FY2017 · CA